Riskpilot← Back to searchSign inGet full accessSENJA BIOPROCESSING AS
ASActiveOrg 913188209Øyfjordveien 49, 9388 FjordgardManufacture of oils and fats · NACE 1041Est. 20140 employees
Revenue 2024
NOK 0
EBITDA margin
—
-44% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK 20K
+48% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -12K | -44% |
| Net profit | NOK 20K | +48% |
| Total assets | NOK 929K | +2% |
| Equity | NOK 928K | +2% |
| Employees | 0 | — |
Legal name
SENJA BIOPROCESSING AS
Org number
913188209
Legal form
Aksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
8. februar 2014
Share capital
NOK 2 144 100
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og et styremedlem i felleskap eller 3 styremedlemmer i fellesskap.
Company purpose
Foredling av biprodukter fra fisk og annen marin foredling, samt deltakelse i andre selskap som kan være med på å forsterke selskapets hovedaktivitet.
Address
Øyfjordveien 49, 9388 Fjordgard
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 865 | 0 | 0 | 0 | 0 |
| Staff expenses | 53 | −0 | −0 | −0 | −0 |
| EBITDA | 801 | −17 | −6 | −8 | −12 |
| Depreciation & amort. | −210 | −0 | −0 | −0 | −0 |
| EBIT | 591 | −17 | −6 | −8 | −12 |
| Net financials | 3 | 1 | 6 | 21 | 31 |
| Profit before tax | 594 | −16 | 0 | 13 | 20 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 594 | −16 | 0 | 13 | 20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 911 | 895 | 895 | 910 | 929 |
| Equity | 911 | 895 | 895 | 908 | 928 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 2 | 1 |
| Total debt | 0 | 0 | 0 | 2 | 1 |
EBITDA margin
-1174700.0%
This company
15.8%
Market median
-7434910% vs market
20202024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20202024
Net profit margin
1952300.0%
This company
8.1%
Market median
+24102369% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 47.41% | 47.41% | 2022 | |
| Company | 15.44% | 15.44% | 2022 | |
| Company | 13.99% | 13.99% | 2022 | |
| Company | 7.72% | 7.72% | 2022 | |
| Company | 7.72% | 7.72% | 2022 | |
| Individual | 7.72% | 7.72% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENJA BIOPROCESSING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marius Berntsen | Chairman | 0 companies |
| Ørjan Uteng Berntsen | Board of Directors | 0 companies |
| Werner Hansen | Board of Directors | 0 companies |